Trump plans to nominate Dr. Mehmet Oz to oversee Medicare, Medicaid and Obamacare
President-elect
The selection of Oz, who lost to
The
The centers are part of the
"CMS touches virtually every family in America through Medicaid and Medicare, and it's probably the most challenging technical, policy and political job in government," said
In a statement announcing his choice, Trump said that Oz would "work closely with
Oz, a heart surgeon and the son of Turkish immigrants, does not have experience running a large federal bureaucracy. Past leaders of the agency have typically had experience working in roles that dealt broadly with health insurance policy, including government positions.
But Oz has weighed in on Medicare policy, helping to write a 2020 opinion column in Forbes arguing for a universal health coverage system, in which every American not covered by Medicaid would be enrolled in a private Medicare Advantage plan. The coverage expansion, the column said, would be financed by an "affordable 20% payroll tax," and would eliminate employer health coverage and the government Medicare program.
That strategy would be far out of the mainstream of conservative health policy. In 2019, Vice President
Oz will also be pressed to outline an agenda for Medicaid, the joint federal-state program that covers more than 70 million poor and disabled Americans. Republican lawmakers and conservative policy experts in recent months have pressed for major changes to the program, including cutting federal funding for it and tightening rules for eligibility.
The agency also oversees insurance marketplaces established by the Affordable Care Act, known as Obamacare. Trump unsuccessfully tried to overturn large portions of the law during his first term, and has been vague about his ambitions for it now. Oz has supported the law's goal of expanded health insurance coverage, though he has been critical of its details, characterizing it as a government takeover of the health care system.
Oz has frequently clashed with other medical experts. In the early days of the pandemic, he promoted the malaria drugs hydroxychloroquine and chloroquine to ward off the coronavirus, medicines that were shown to be ineffective in treating the virus. A decade ago, he went before a
In his run for the
This article originally appeared in
Fed’s recent rate cuts could improve borrowing options for state and local government projects
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News